Angion Biomedica Corp. announced On August 28, 2023, Assaf Segal submitted his resignation from the Board of Directors of Elicio Therapeutics Inc., which resignation was effective immediately. Mr. Segal?s resignation from the Board follows his recently announced upcoming departure from his role as Chief Executive Officer at Clal Biotechnology Industries and was not the result of any disagreement with the Company or any matter relating to the Company?s operations, policies or practices.